Aberrant pre-mRNA processing in cancer.

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Gene expression relies on accurate information flow from DNA to RNA to protein.
• Dysregulation of this process is a hallmark of all cancer types.
• RNA processing, especially splicing, is frequently altered in malignancies.

Purpose of the Study:

• To review the current understanding of RNA processing dysregulation in cancer.
• To focus on mutations in RNA splicing machinery prevalent in hematologic malignancies.
• To explore therapeutic strategies targeting RNA processing alterations.

Main Methods:

• Literature review of current research on RNA processing in cancer.
• Analysis of mutations in RNA splicing factors.
• Examination of downstream effects and affected pathways.
• Identification of therapeutic applications and selective toxicity mechanisms.

Main Results:

• Mutations in RNA splicing factors are highly prevalent in hematologic malignancies.
• These mutations lead to dysregulated RNA processing with significant downstream effects.
• Specific genes and common pathways are perturbed by these splicing factor mutations.
• Alterations in RNA processing can be exploited for therapeutic benefit.

Conclusions:

• Dysregulated RNA processing, particularly via splicing factor mutations, is critical in cancer development.
• Targeting these RNA processing defects presents promising therapeutic avenues for hematologic malignancies.
• Understanding these mechanisms enhances strategies for selective cancer cell killing.